Head-to-Head Comparison Between Biparametric and Multiparametric MRI for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.

OBJECTIVE The purpose of this study was to perform a systematic review and meta-analysis of a head-to-head comparison between the performance of biparametric MRI (bpMRI; only T2-weighted imaging and DWI) and that of multiparametric MRI (mpMRI; T2-weighted imaging, DWI, dynamic contrast-enhanced MRI) for the diagnosis of prostate cancer. MATERIALS AND METHODS The PubMed and Embase databases were searched up to November 11, 2017. The search included diagnostic test accuracy studies that compared bpMRI and mpMRI for prostate cancer diagnosis with histopathologic findings from biopsy or radical prostatectomy as the reference standard. Methodologic quality was evaluated with the revised Quality Assessment of Diagnostic Accuracy Studies tool. Sensitivity and specificity were pooled by means of bivariate and hierarchic summary ROC (HSROC) modeling and graphically presented with HSROC plots. Meta-regression analysis and multiple subgroup analyses were used to compare the diagnostic performances of bpMRI and mpMRI. RESULTS Twenty studies (2142 patients) were included. Pooled sensitivity and specificity were 0.74 (95% CI, 0.66-0.81) and 0.90 (95% CI, 0.86-0.93) for bpMRI and 0.76 (95% CI, 0.69-0.82) and 0.89 (95% CI, 0.85-0.93) for mpMRI. MRI protocol (bpMRI vs mpMRI) was not a significant factor in heterogeneity (p = 0.83). In 26 subgroups evaluated on the basis of stratification to clinicopathologic, study, and MRI characteristics, MRI protocol (bpMRI vs mpMRI) was not a significant factor in heterogeneity in any subgroup (p = 0.25-0.97). CONCLUSION A head-to-head comparison showed that the performance of bpMRI was similar to that of mpMRI in the diagnosis of prostate cancer. Consistent results were found in multiple subgroup analyses.

[1]  Susan Mallett,et al.  QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies , 2011, Annals of Internal Medicine.

[2]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[3]  Thomas Hambrock,et al.  Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. , 2013, Radiology.

[4]  R. Semelka,et al.  Gadolinium Retention and Toxicity-An Update. , 2017, Advances in chronic kidney disease.

[5]  Arturo Brunetti,et al.  Biparametric 3T Magnetic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2? , 2016, European journal of radiology.

[6]  Sang Hyun Choi,et al.  Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical Review for Clinical Researchers-Part I. General Guidance and Tips , 2015, Korean journal of radiology.

[7]  Sang Hyun Choi,et al.  Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical Review for Clinical Researchers-Part II. Statistical Methods of Meta-Analysis , 2015, Korean journal of radiology.

[8]  A. Afifi,et al.  Multi-parametric MRI and PI-RADS (V1) scoring system: New inception in cancer prostate diagnosis to evaluate diagnostic performance of different score combinations , 2016 .

[9]  H. Merisaari,et al.  Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy , 2015, Journal of magnetic resonance imaging : JMRI.

[10]  H. Thomsen,et al.  Biparametric versus multiparametric MRI in the diagnosis of prostate cancer , 2016, Acta radiologica open.

[11]  Tao Yu,et al.  Diagnostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Detecting Residual or Recurrent Prostate Cancer After Radical Prostatectomy: A Pooled Analysis of 12 Individual Studies , 2015, Cell Biochemistry and Biophysics.

[12]  Carlos Nicolau,et al.  Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study. , 2017, Radiology.

[13]  P. Albers,et al.  MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy , 2014, European Radiology.

[14]  Rémi Souchon,et al.  Quantitative Analysis of Prostate Multiparametric MR Images for Detection of Aggressive Prostate Cancer in the Peripheral Zone: A Multiple Imager Study. , 2016, Radiology.

[15]  Kazuro Sugimura,et al.  Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.

[16]  H. Hricak,et al.  Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference , 2016, European Radiology.

[17]  Victor M Montori,et al.  Conducting systematic reviews of diagnostic studies: didactic guidelines , 2002, BMC medical research methodology.

[18]  Jonathan J Deeks,et al.  The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. , 2005, Journal of clinical epidemiology.

[19]  J. Babb,et al.  Length of capsular contact for diagnosing extraprostatic extension on prostate MRI: Assessment at an optimal threshold , 2016, Journal of magnetic resonance imaging : JMRI.

[20]  S. Woo,et al.  Assessment of deep myometrial invasion of endometrial cancer on MRI: added value of second-opinion interpretations by radiologists subspecialized in gynaecologic oncology , 2017, European Radiology.

[21]  Tyler J. Fraum,et al.  Gadolinium‐based contrast agents: A comprehensive risk assessment , 2017, Journal of magnetic resonance imaging : JMRI.

[22]  Karin Haustermans,et al.  Multiparametric MRI for prostate cancer localization in correlation to whole‐mount histopathology , 2013, Journal of magnetic resonance imaging : JMRI.

[23]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.

[24]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[25]  D. Margolis,et al.  PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 2016, European urology.

[26]  H. G. van der Poel,et al.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2017, European urology.

[27]  F. Beuvon,et al.  Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer , 2011, Prostate Cancer and Prostatic Diseases.

[28]  P. Choyke,et al.  Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2. , 2017, Radiology.

[29]  A. Evans,et al.  Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[30]  M. Sumura,et al.  Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer , 2008, Acta radiologica.

[31]  M. Agha,et al.  3 Tesla MRI surface coil: Is it sensitive for prostatic imaging?? , 2015 .

[32]  J. Cho,et al.  Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis. , 2018, European urology.

[33]  S. Park,et al.  Successful Publication of Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy , 2016, Korean journal of radiology.

[34]  Simone Schrading,et al.  Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen. , 2017, Radiology.

[35]  M. Roethke,et al.  Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance , 2015, Prostate Cancer and Prostatic Disease.

[36]  N. Lumen,et al.  Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. , 2017, Clinical radiology.

[37]  P. Choyke,et al.  Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate-specific Antigen in the Detection of Prostate Cancer: A Validation Study in a Biopsy-naive Patient Population. , 2016, Urology.

[38]  P. Dean,et al.  Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD Trial) , 2017, Journal of magnetic resonance imaging : JMRI.